Trials / Completed
CompletedNCT06293391
The Effect of Patient Position Changes on Advanced Cardiac Indices in Cancer Surgery
The Impact of Patient Position Changes on Advanced Hemodynamic Indices in Laparoscopic and Open Major Abdominal Cancer Surgeries
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
Esophageal Doppler Monitoring (Deltex CardioQ Esophageal Doppler Monitor, ODM) is used to manage patients' fluid therapy by non-invasively measuring continuous cardiac output with an esophageal probe. The aim of this study was to compare the effects of patient position changes on cardiac indices and vital signs in patients who underwent major abdominal cancer surgery with laparoscopic and open surgery using ODM.
Detailed description
Patients who underwent major abdominal cancer surgery using ODM in the operating room of our hospital between November 2021 and November 2022 were identified from the Anesthesiology Clinic records and examined according to whether they were operated with open or closed (laparoscopic) methods. Demographic data, vital signs, amount of bleeding, type and amount of fluid administered, and the results of cardiac index measurements performed with the ODM device in the supine and trendelenburg positions (45 degrees) were analyzed. Parameters recorded with the ODM device; CO: Cardiac output, FTc: Flow time corrected, PV: Peak velocity, SD: Stroke distance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | cardiac indices in supine and trendelenburg position | Cardiac indices in supine and trendelenburg position in patients undergoing open or laparoscopic major cancer surgery |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2023-03-01
- Completion
- 2024-02-05
- First posted
- 2024-03-05
- Last updated
- 2024-11-07
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06293391. Inclusion in this directory is not an endorsement.